← Back to Search

PeptiStrong for Muscle Strength Enhancement

N/A

Recruiting

Research Sponsored by Nuritas Ltd

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Males & females between 19 and 40 years of age

Hormonal contraceptives including oral contraception, hormone birth control patch, vaginal contraceptive ring, injectable contraceptives, or hormone implant.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 56 days supplementation

Awards & highlights

Study Summary

This trial tests how well a supplement called PeptiStrong helps young people build muscle strength and endurance when combined with exercise.

Who is the study for?

This trial is for men and women aged 19-40 with a BMI of 18.5 to 29.9, who are willing to follow an exercise program three times a week without engaging in other vigorous activities two days before testing. Participants should maintain their current lifestyle, including diet and sleep patterns, avoid NSAIDs and alcohol before visits, and use contraception if necessary.Check my eligibility

What is being tested?

The study tests PeptiStrong's effectiveness on muscle strength when combined with regular exercise compared to a placebo (an inactive substance). It's randomized (participants are assigned by chance) and double-blind (neither researchers nor participants know who gets what), ensuring unbiased results.See study design

What are the potential side effects?

Potential side effects aren't specified here but generally could include digestive discomfort or allergic reactions from the supplement, as well as typical exercise-related issues like muscle soreness or strain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 19 and 40 years old.

Select...

I am using a form of hormonal birth control.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 56 days supplementation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~56 days supplementation

This trial's timeline: 3 weeks for screening, Varies for treatment, and 56 days supplementation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

randomised, double-blind, placebo controlled study to evaluate the effect of PeptiStrong in conjunction with an exercise program on muscle strength in young males and females.

Secondary outcome measures

To assess the effects of PeptStrong in conjunction with exercise

Other outcome measures

effect of PeptiStrong in conjunction with exercise on future exploratory endpoints including blood biomarkers of muscle homeostasis pre and post exercise

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: PeptiStrong - fava bean hydrolysate preparationExperimental Treatment1 Intervention

PeptiStrong 2.4g/day will be supplemented as 5 capsules (480mg each) taken with approx. 150mL water at breakfast once per day for 56 days

Group II: Silicated micro-crystalline cellulose (SMCC)Placebo Group1 Intervention

The placebo 2.4g/day will be supplemented as 5 capsules taken with approx. 150mL water at breakfast once per day for 56 days

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Nuritas LtdLead Sponsor

4 Previous Clinical Trials

146 Total Patients Enrolled

2 Trials studying Muscle Injuries

46 Patients Enrolled for Muscle Injuries

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any opportunities for participants to join this trial?

"As per the clinicaltrials.gov website, this medical trial is actively seeking participants. This experiment was initially uploaded on August 9th 2023 with its most recent alteration occurring November 17th of that same year."

Answered by AI

Does the research team have an upper age restriction for enrollment?

"As indicated in the trial's qualification criteria, participants must be between 19 and 40 years old."

Answered by AI

To what extent has the enrollment of participants in this investigation been successful?

"Affirmative. According to clinicaltrials.gov, this medical experiment was initially uploaded on August 9th 2023 and has been recently modified on November 17th 2023. The researchers require 72 participants from a single site for their trial."

Answered by AI

Is it possible for me to enroll in this clinical trial?

"Patients who suffer from muscle-related injuries and are within the 19 to 40 age range can sign up for this medical trial. A total of 72 participants will be accepted into the study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Effects of PeptiStrong and Exercise to Enhance Muscle Strength in Young Subjects

2023. "The Effects of PeptiStrong and Exercise to Enhance Muscle Strength in Young Subjects". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05946746.